Clinical Trial: GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795437) titled 'GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma' on Aug. 26.

Brief Summary: This is a diagnostic study.This clinical trial aims to evaluate the diagnostic performance and safety of the novel radiotracer 18F-X12 in patients with hepatocellular carcinoma (HCC), and to provide evidence supporting a new approach for its early diagnosis, accurate staging and recurrence assessment.

Study Start Date: Aug. 25

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma (HCC)

Intervention: DIAGNOSTIC_TEST: 18F-X12 PET/CT

Participants will receive a single intravenous injection of 18F-X12, and undergo PET/CT imaging ...